Related Experiment Video
Updated: May 15, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
miRNAs and their putative roles in the development and progression of Parkinson's disease
1Department of Neurobiology, A.I. Virtanen Institute, University of Eastern Finland Kuopio, Finland.
Abstract:
Small regulatory RNAs, such as miRNAs, are increasingly being recognized not only as regulators of developmental processes but contributors to pathological states. The number of miRNAs determined experimentally to be involved in Parkinson's disease (PD) development and progression is small and includes regulators of pathologic proteins, neurotrophic factors, and xenobiotic metabolizing enzymes. PD gene-association studies have also indicated miRNAs in the pathology. In this review, we present known miRNAs and their validated targets that contribute to PD development and progression. We also incorporate data mining methods to link additional miRNAs with non-experimentally validated targets and propose additional roles of miRNAs in neurodegenerative processes. Furthermore, we present the potential contribution of next-generation-sequencing approaches to elucidate mechanisms and etiology of PD through discovery of novel miRNAs and other non-coding RNA classes.
Insights
MicroRNAs (miRNAs) are small RNAs regulating cellular processes and contributing to Parkinson's disease (PD) pathology. This review explores known and potential miRNA roles in PD development and progression.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- Small regulatory RNAs, microRNAs (miRNAs), are implicated in both normal development and disease.
- The specific role of miRNAs in Parkinson's disease (PD) pathogenesis is an emerging area of research.
- Existing studies link a limited number of miRNAs to PD through regulation of key proteins and pathways.
Purpose of the Study:
- To review experimentally validated miRNAs and their targets involved in Parkinson's disease.
- To identify potential novel miRNAs and their targets in PD using data mining approaches.
- To discuss the role of next-generation sequencing in discovering non-coding RNAs in PD.
Main Methods:
- Literature review of experimentally validated miRNA targets in PD.
- Bioinformatic data mining to predict novel miRNA-target interactions.
- Analysis of next-generation sequencing data for non-coding RNA discovery.
Main Results:
- Compilation of known miRNAs and their validated targets contributing to PD.
- Identification of potential additional miRNAs linked to PD through computational analysis.
- Highlighting the utility of advanced sequencing for novel miRNA discovery in neurodegeneration.
Conclusions:
- miRNAs are significant contributors to the development and progression of Parkinson's disease.
- Data mining and next-generation sequencing offer powerful tools to expand our understanding of miRNA involvement in PD.
- Further research into non-coding RNAs is crucial for elucidating PD mechanisms and etiology.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Neural Regulation
MicroRNAs
MicroRNAs